[o1–12–01]: [18f]flutemetamol amyloid scanning in a phase iii amnestic mild cognitive impairment study: additional influence of other biomarkers in estimating risk of conversion to probable alzheimers disease
Alzheimer's & Dementia(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要